サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1768769

経カテーテル心臓弁の世界市場

Transcatheter Heart Valves

出版日
ページ情報
英文 247 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
経カテーテル心臓弁の世界市場
出版日: 2025年07月11日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 247 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

経カテーテル心臓弁の世界市場は2030年までに436億米ドルに達する見込み

2024年に173億米ドルと推定される経カテーテル心臓弁の世界市場は、2030年には436億米ドルに達し、分析期間2024-2030年のCAGRは16.6%で成長すると予測されます。本レポートで分析したセグメントの1つである経カテーテル大動脈弁（TAV）は、CAGR 16.9％を記録し、分析期間終了までに314億米ドルに達すると予測されます。経カテーテル僧帽弁（TMV）セグメントの成長率は、分析期間でCAGR 15.9％と推定されます。

米国市場は44億米ドル、中国はCAGR21.2％で成長予測

米国の経カテーテル心臓弁市場は、2024年に44億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに111億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.6%と14.1%と予測されています。欧州では、ドイツがCAGR約12.8%で成長すると予測されています。

世界の経カテーテル心臓弁市場- 主要動向と促進要因のまとめ

経カテーテル心臓弁が心臓病学のゲームチェンジャーとなる理由とは？

経カテーテル心臓弁は、大動脈弁狭窄症などの重篤な心臓弁膜症を患う患者に対して、従来の開心術に代わる低侵襲手術を提供し、心臓病学分野における画期的な進歩を象徴しています。大きな胸部切開と人工心肺装置を必要とする従来の外科的弁置換術とは異なり、経カテーテル心臓弁置換術では、通常、鼠径部または胸部の小さな切開創からカテーテルを介して折りたたみ可能な弁を挿入します。一旦弁が設置されると、弁は拡張して直ちに機能し始め、開心術の必要なく正常な血流を回復します。このアプローチは、従来の手術に伴う身体的外傷や回復時間を大幅に軽減するため、高齢の患者や手術リスクが高く、従来の手術の適応とならない患者にとって、実行可能な選択肢となります。この分野の主要な技術は経カテーテル的大動脈弁置換術（TAVR）であり、その有効性が証明され、合併症発生率が外科的手術に比べて低いことから、広く採用されています。TAVRの成功は、僧帽弁や三尖弁を含む他の心臓弁に対する経カテーテルソリューションの開発に拍車をかけ、経カテーテル弁インターベンションの治療範囲を拡大した。在院日数の短縮、術後疼痛の軽減、回復時間の短縮など、経カテーテル心臓弁は患者の予後を改善するだけでなく、心血管系治療における標準治療を変革しています。

経カテーテル心臓弁の革新は、心臓治療の未来をどのように形成しているのでしょうか？

経カテーテル心臓弁の分野は、材料科学、機器設計、手技の進歩に牽引され、急速な技術革新を目の当たりにしており、その結果、これらの救命機器の安全性、有効性、汎用性が向上しています。最も重要な技術革新のひとつは、耐久性が向上し、複雑な解剖学的構造に適応する次世代経カテーテルバルブの開発です。これらの新デバイスには、ニチノール（形状記憶合金）のような先進素材が組み込まれており、これにより弁が自己拡張し、患者の解剖学的構造により適合しやすくなるため、より優れた適合性が確保され、漏れや合併症のリスクが軽減されます。もう1つの重要な技術革新は、組織工学的および生体吸収性の弁コンポーネントの使用であり、これらは弁装置の長期的な性能を向上させ、石灰化のリスクを最小限に抑えることを目的としています。さらに、新しいデリバリーシステムとより小さなカテーテルサイズにより、より小さな血管からのアクセスが可能となり、血管合併症のリスクがさらに軽減され、より少ない外傷でこれらの手技を行うことが可能となっています。3D心エコーやCTガイド下ナビゲーションなどの画像技術の革新もまた、手技の精度を高め、弁の正確な配置を可能にし、合併症のリスクを減らしています。デジタルヘルス技術の統合も大きな動向であり、一部の機器にはセンサーやワイヤレスモニタリングシステムが組み込まれ、弁の性能や患者の健康状態に関するリアルタイムのデータが提供されるため、事前の管理やタイムリーな介入が可能になっています。

経カテーテル心臓弁の採用と開発に影響を与える課題とは？

経カテーテル心臓弁の普及と開発は、その革新的な可能性にもかかわらず、いくつかの重大な課題に直面しています。主な課題の一つは、これらの手技に関連する高コストです。経カテーテル弁置換術、特にTAVRは、高価な機器、専門的なトレーニング、高度な画像診断や手技用機器を伴う資源集約的なプロセスであるため、特に低所得層や地方の環境では、アクセスが制限される可能性があります。もう一つの課題は、患者選択と手技計画の複雑さです。直接視認しながら行う従来の外科的弁置換術とは異なり、経カテーテル手技は、弁の配置をガイドするために、心エコー、CTスキャン、透視などの画像診断に大きく依存しています。このため、高度な専門知識と正確な解剖学的評価が要求され、新しいオペレーターにとっては学習曲線が険しくなり、経験の浅いセンターではこれらの手技の統合が複雑になります。加えて、経カテーテル心臓弁の長期的な耐久性は、特に、装置の寿命より長くなる可能性のある若い患者にとっては、依然として懸念事項です。新しい素材やデザインは耐久性の延長を目指しているが、10～15年以上の長期成績に関するデータはまだ限られており、これらの手技に最適な患者プロファイルを決定することを困難にしています。カテーテル挿入時の弁傍漏、弁血栓症、血管損傷などの合併症のリスクも、患者の転帰に影響を与えうる課題となっています。規制状況や償還の問題も情勢を複雑にしており、経カテーテルデバイスの承認基準や償還基準は地域によって大きく異なることが多いです。

経カテーテル心臓弁市場の成長を促す要因は何か？

経カテーテル心臓弁市場の成長は、心血管疾患の有病率の上昇、世界人口の高齢化、デバイス設計や手技における技術進歩など、いくつかの要因によってもたらされます。主な要因の一つは、特に高齢者における大動脈弁狭窄症やその他の心臓弁膜症の罹患率の増加であり、高齢者は手術リスクが高いことが多いため、低侵襲の経カテーテル治療が有効である可能性が高いです。世界人口の高齢化に伴い、回復が早く合併症の少ない低侵襲治療への需要が高まっており、経カテーテル心臓弁はますます好まれる選択肢となっています。もう一つの重要な推進力は、これらのデバイスの臨床適応の拡大です。当初は高リスクの外科手術候補者向けに承認されていた経カテーテル弁置換術は、外科的弁置換術と同等かそれ以上の治療成績が実証された臨床試験を経て、現在では低リスクの患者にも実施されるようになっています。このような適応の拡大により、治療の対象となる患者層が大幅に拡大し、市場成長の原動力となっています。技術的進歩も市場を後押ししており、再配置・回収可能な弁、より小型の送達システム、高度な画像診断ツールなどの技術革新が、手技をより安全で効果的なものにしています。さらに、心臓専門医、外科医、画像診断の専門家が協力して最善の治療計画を決定するハートチーム・アプローチの採用が拡大していることで、患者の選択と手技の結果が改善され、経カテーテルインターベンションの全体的な成功率が高まっています。専門的なトレーニングや教育イニシアティブに支えられた世界中の病院における経カテーテル弁専用プログラムの台頭も、必要なインフラや専門知識の構築によって市場の成長に寄与しています。最後に、経カテーテル心臓弁の利点に対する認識の高まりは、いくつかの地域における有利な償還政策と相まって、これらの手技をより身近なものとし、より高い採用率を牽引しています。これらの要因を総合すると、経カテーテル心臓弁市場は堅調な成長軌道を描いており、インターベンショナル・カーディオロジーにおける重要な構成要素と位置付けられています。

セグメント

製品タイプ（経カテーテル大動脈弁（TAV）、経カテーテル僧帽弁（TMV））、エンドユーザー（病院、カテーテル検査室）

調査対象企業の例

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP17639

Global Transcatheter Heart Valves Market to Reach US$43.6 Billion by 2030

The global market for Transcatheter Heart Valves estimated at US$17.3 Billion in the year 2024, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the end of the analysis period. Growth in the Transcatheter Mitral Valve (TMV) segment is estimated at 15.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.4 Billion While China is Forecast to Grow at 21.2% CAGR

The Transcatheter Heart Valves market in the U.S. is estimated at US$4.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Global Transcatheter Heart Valves Market - Key Trends and Drivers Summarized

What Makes Transcatheter Heart Valves a Game-Changing Advancement in Cardiology?

Transcatheter heart valves represent a groundbreaking advancement in the field of cardiology, offering a minimally invasive alternative to traditional open-heart surgery for patients suffering from severe heart valve diseases such as aortic stenosis. Unlike conventional surgical valve replacement procedures that require a large chest incision and a heart-lung machine, transcatheter heart valve procedures involve the insertion of a collapsible valve via a catheter, typically through a small incision in the groin or chest. Once in place, the valve expands and starts functioning immediately, restoring normal blood flow without the need for open-heart surgery. This approach significantly reduces the physical trauma and recovery time associated with traditional surgery, making it a viable option for elderly patients or those with high surgical risk who may not be candidates for conventional procedures. The primary technology in this field is Transcatheter Aortic Valve Replacement (TAVR), which has gained widespread adoption due to its proven efficacy and lower complication rates compared to surgical options. The success of TAVR has spurred the development of transcatheter solutions for other heart valves, including the mitral and tricuspid valves, expanding the therapeutic scope of transcatheter valve interventions. With shorter hospital stays, reduced postoperative pain, and faster recovery times, transcatheter heart valves are not only improving patient outcomes but are also transforming the standard of care in cardiovascular treatment.

How Are Innovations in Transcatheter Heart Valves Shaping the Future of Cardiac Care?

The field of transcatheter heart valves is witnessing rapid innovation, driven by advancements in material science, device design, and procedural techniques, which are enhancing the safety, efficacy, and versatility of these life-saving devices. One of the most significant innovations is the development of next-generation transcatheter valves that offer enhanced durability and adaptability to complex anatomies. These new devices incorporate advanced materials such as nitinol-a shape-memory alloy that allows the valves to be self-expanding and more conformable to the patient’s anatomy, ensuring a better fit and reducing the risk of leaks or complications. Another key innovation is the use of tissue-engineered and bioresorbable valve components, which aim to improve the long-term performance of the devices and minimize the risk of calcification. Furthermore, new delivery systems and smaller catheter sizes are making it possible to perform these procedures with even less trauma, allowing access through smaller vessels and further reducing the risk of vascular complications. Innovations in imaging technology, such as 3D echocardiography and CT-guided navigation, are also enhancing procedural precision, enabling more accurate placement of the valve and reducing the risk of complications. The integration of digital health technologies is another major trend, with some devices incorporating sensors and wireless monitoring systems that provide real-time data on valve performance and patient health, allowing for proactive management and timely interventions.

What Challenges Are Affecting the Adoption and Development of Transcatheter Heart Valves?

Despite their transformative potential, the adoption and development of transcatheter heart valves face several significant challenges that need to be addressed to optimize their use and expand their reach. One of the primary challenges is the high cost associated with these procedures. Transcatheter valve replacement, particularly TAVR, is a resource-intensive process that involves expensive devices, specialized training, and sophisticated imaging and procedural equipment, which can limit accessibility, especially in low-income and rural settings. Another challenge is the complexity of patient selection and procedural planning. Unlike traditional surgical valve replacement, which is performed under direct visualization, transcatheter procedures rely heavily on imaging modalities such as echocardiography, CT scans, and fluoroscopy to guide valve placement. This demands a high level of expertise and precise anatomical assessment, making the learning curve steep for new operators and complicating the integration of these procedures into less experienced centers. Additionally, the long-term durability of transcatheter heart valves remains a concern, especially for younger patients who may outlive the lifespan of the device. Although newer materials and designs are aimed at extending durability, data on long-term outcomes beyond 10-15 years is still limited, making it difficult to determine the optimal patient profile for these procedures. The risk of complications, such as paravalvular leak, valve thrombosis, or vascular damage during catheter insertion, also poses challenges that can impact patient outcomes. Regulatory hurdles and reimbursement issues also complicate the landscape, as the approval and reimbursement criteria for transcatheter devices are often vary significantly between regions.

What Factors Are Driving Growth in the Transcatheter Heart Valve Market?

The growth in the transcatheter heart valve market is driven by several factors, including the rising prevalence of cardiovascular diseases, an aging global population, and technological advancements in device design and procedural techniques. One of the primary drivers is the increasing incidence of aortic stenosis and other valvular heart diseases, particularly among the elderly, who are often at higher surgical risk and thus more likely to benefit from minimally invasive transcatheter options. As the global population ages, the demand for less invasive treatments that offer faster recovery and fewer complications is rising, making transcatheter heart valves an increasingly preferred choice. Another key driver is the expansion of clinical indications for these devices. Originally approved for high-risk surgical candidates, transcatheter valve replacement procedures are now being performed in lower-risk patients, following clinical trials that demonstrated comparable or superior outcomes to surgical valve replacement. This broadening of indications is significantly expanding the patient pool eligible for these treatments, driving market growth. Technological advancements are also propelling the market, with innovations such as repositionable and retrievable valves, smaller delivery systems, and advanced imaging tools that are making the procedures safer and more effective. Furthermore, the growing adoption of heart team approaches-where cardiologists, surgeons, and imaging specialists collaborate to determine the best treatment plan-has improved patient selection and procedural outcomes, enhancing the overall success rate of transcatheter interventions. The rise of dedicated transcatheter valve programs in hospitals around the world, supported by specialized training and educational initiatives, is also contributing to market growth by building the necessary infrastructure and expertise. Lastly, increasing awareness of the benefits of transcatheter heart valves, coupled with favorable reimbursement policies in several regions, is making these procedures more accessible and driving higher adoption rates. These factors collectively indicate a robust growth trajectory for the transcatheter heart valve market, positioning it as a key component of interventional cardiology.

SCOPE OF STUDY:

The report analyzes the Transcatheter Heart Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Transcatheter Aortic Valve (TAV), Transcatheter Mitral Valve (TMV)); End-Use (Hospital, Cath lab)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Transcatheter Heart Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Drive Demand for Transcatheter Heart Valve Procedures
    • Advancements in Valve Design and Delivery Systems Strengthen Business Case for Next-Generation Transcatheter Heart Valves
    • Growing Preference for Minimally Invasive Cardiac Interventions Expands Addressable Market for Transcatheter Heart Valves in High-Risk Patients
    • Shift towards Transcatheter Valve-in-Valve (ViV) Procedures Spurs Adoption for Complex and Repeat Interventions
    • Increasing Use of Transcatheter Aortic Valve Replacement (TAVR) Expands Market Potential in Treating Aortic Stenosis
    • Rising Adoption of Transcatheter Mitral Valve Replacement (TMVR) Propels Growth in Mitral Regurgitation Treatment
    • Growing Integration of Imaging and Navigation Technologies Enhances Precision and Success Rates of Transcatheter Valve Procedures
    • Rising Interest in Personalized and Patient-Specific Heart Valve Solutions Expands Market for Customizable Transcatheter Devices
    • Focus on Early Detection and Treatment of Heart Valve Disorders Propels Demand for Less Invasive Valve Replacement Solutions
    • Expanding Application of Transcatheter Heart Valves in Treating Congenital Heart Defects Sustains Market Growth in Pediatric and Adult Congenital Segments
    • Rising Focus on Expanding Indications Beyond Aortic and Mitral Valves Enhances Market Potential in Treating Tricuspid and Pulmonary Valve Diseases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Transcatheter Aortic Valve (TAV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Transcatheter Mitral Valve (TMV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Transcatheter Heart Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cath lab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • INDIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AFRICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030

IV. COMPETITION